Disclosure: Why notPPHM? InvestorsHub was paid $1,000 by Red Chip Companies Inc to disseminate the following advertisement. Are any of you out there Red Chip Co.,Inc, propaganda people? Or similar product anti-propagandists? Any Pro-Bavi/PPHM? In only a few years we have gone from belief of internet content to total mistrust. The artificial brain is no more honest that the people who assemble content! Seeing is believing? No more. Initially the photographs were masterful reproduction of nature. Now the spectacular ones are superimpositions manipulated by Photoshop.So So the IHub ad asks, "Why did the National Institutes of Health and Department of Defense Fund Research AV Therapeutics' Prostate Cancer Drug? NIH and the US Defense Dept did the same for PPHM Bavituximabt YEARS ago. The IHub ad continues "AV Therapeutics has enlisted fifteen leading institutions to test their prostate cancer drug, Capradine, for a Phase I Clinical Trial, Led by Howard Scher of the Memorial Sloan Kettering Cancer Center. Way early for this one. PPHM has phase III Sunrise Trials around the known world now, trying out its anti-solid cancer drug, Bavituximab, an immune system booster.IHub ad continues, "AV Therapeutics has identified and patented a chemo therapeutic drug called Capridine that has shown in preclinical models to have specific activity against prostate and colon cancer. OMG. Why no ads for Bavi lie this? Gest some more investor money in. Look at this week trading volume. Pitiful. Legend has it that ethical pharmas do not advertise to the public, but instead give free drug samples, stethoscopes, trips, and meetings to doctors. Anyway, "...AV's....[prostate] drug is expected to be the frontline AV Therapeutics product specifically in prostate cancer where limited chemotherapy exists at present." Wonder who worded that ad?! Phase I?! Why not BAVI?! PPHM has its PIII clinical Sunrise Trials at US, European, and Asian sites...and...and..Less than $1million in PPHM stock changed hands today. Remember the difference between ethical and fly-by-night pharmas. Advertising to the public. No hype. No easy money here...although trading looks pretty good despite the anemic volume. Maybe that's the secret in layman's terms: latch onto a stock with enormous short-term prospect to protect your downside , and then play it for all it's worth. No thanks. I'm holding my core and hoping. Don't have time for market shenanigans. 10 years ago I said here that politics would ruin the price structure for Bavi sooner than competition. Speaking of competition: How aboutthe biotech news today for instance. I didn't even notice the school...big name back east... found an element in one line of T-cells that fought a patient's advanced metastatic solid cancer and reversed it. Essentially brought her back to life with a transfusion of a billion cloned Tcells specific for her tumor. Not quite ready for that on a mass production basis. Not in clinical trials. A single case. Don't know duration of response. But it is a new and dramatic therapeutic strategy. Stick with Bavi for the immediate future. The fabulous ace-kicker card-in-the-hole with PPHM is its in-house MAB production facility all geared up for production of Bavituximab.. This is going to be good. So with the lousy general market, disinformation accelerating here, new cures daily, and poor PPHM track record, only the smart ones still have all their play money trapped here, On a personal note, itt has been a long week of interesting patients, and only a few minutes ago I completed 3 hours of reviewing insurance reimbursement/medical necessity/standard of care indications for cochlear implants and bone-anchored hearing aids. Now to the weekend. Stress reduction everyone, I think this is going to work out well. Not a serious misstep yet. Cheers!
AI
